Related Experiment Video
Updated: Jun 25, 2026
09:00
Characterization of Immune Cells and Proinflammatory Mediators in the Pulmonary Environment
Published on: June 24, 2020
IL-1beta augments TNF-alpha-mediated inflammatory responses from lung epithelial cells
Sara Saperstein1, Linlin Chen, David Oakes
1Department of Environmental Medicine, University of Rochester School of Medicine, Rochester, New York 14642, USA. Sara_Saperstein@urmc.rochester.edu
Summary
Interleukin-1beta (IL-1beta) enhances inflammatory lung disease by increasing tumor necrosis factor-alpha (TNF-alpha) receptors on lung cells. This study reveals how IL-1beta modifies TNF-alpha receptor activity, impacting inflammatory responses.
Area of Science:
- Immunology
- Pulmonary Medicine
- Cell Biology
Background:
- Interleukin-1beta (IL-1beta) and tumor necrosis factor-alpha (TNF-alpha) are key mediators in inflammatory lung diseases.
- IL-1beta activation often coincides with TNF-alpha production, suggesting a functional interplay.
- The precise mechanisms by which IL-1beta influences TNF-alpha-induced epithelial responses remain incompletely understood.
Purpose of the Study:
- To investigate the impact of IL-1beta on TNF-alpha-mediated chemokine production in mouse pulmonary epithelial cells (MLE-15).
- To determine how IL-1beta affects the surface expression and shedding of TNF receptors (TNFR1 and TNFR2).
- To elucidate the role of specific TNF receptors in mediating IL-1beta's effects on epithelial cell function.
Main Methods:
- Treatment of MLE-15 cells with IL-1beta and/or TNF-alpha.
- Analysis of soluble and cell surface TNF receptor levels using techniques like siRNA.
- Quantification of chemokine mRNA and protein expression (MIP-2 and KC).
- Utilized TNFR1 neutralizing antibody to assess receptor function.
Main Results:
- IL-1beta rapidly and persistently increased both soluble and surface TNFR2, an effect dependent on TNFR1.
- Silencing TNFR2 expression shifted IL-1beta's effects, increasing surface and shed TNFR1, indicating selective receptor modulation.
- IL-1beta pretreatment enhanced TNF-alpha-induced production of macrophage inflammatory protein (MIP)-2 and KC at both mRNA and protein levels.
- TNFR1 mediated TNF-alpha-induced MIP-2 production, while both TNFR1 and TNFR2 may contribute to KC production.
Conclusions:
- IL-1beta modulates TNF-alpha-mediated inflammatory lung diseases by enhancing epithelial cell TNF receptor surface expression.
- These findings highlight a post-transcriptional mechanism where IL-1beta selectively alters TNF receptor composition and shedding.
- Understanding this IL-1beta-TNF receptor interaction is crucial for developing targeted therapies for inflammatory lung conditions.
More Related Videos
08:16An IL-8 Transiently Transgenized Mouse Model for the In Vivo Long-term Monitoring of Inflammatory Responses
Published on: July 7, 2017
10:39Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
Published on: April 16, 2019
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:16TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
02:26NF-κB-dependent Signaling Pathway
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:12Chronic Inflammation: Introduction
Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...